Printer Friendly

AxoGen elects Kevin Leach as VP of Marketing.

M2 EQUITYBITES-March 14, 2016-AxoGen elects Kevin Leach as VP of Marketing


Surgical solutions company AxoGen (NasdaqCM:AXGN) revealed on Monday that it has appointed Kevin Leach as vice president of Marketing

Effective immediately, Leach is responsible for the company's global marketing strategies and functions, reporting directly to president and CEO and Karen Zaderej.

Most recently, Leach has served as the vice president, Global Knee Marketing of Stryker Corporation, a medical technology company.

Leach previously worked as vice president, Americas, Wound Therapeutics & Critical Care as well as global marketing leader for ConvaTec, a Bristol-Myers Squibb company, where he led the launch of new products globally.

In the past, Leach was part of Zimmer UK, a medical device company, where he headed a newly established division for the Orthopaedic business unit focusing on market development and commercialisation of an injectable Hyaluronic Acid for the relief of joint pain.

((Comments on this story may be sent to

COPYRIGHT 2016 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2016 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 EquityBites (EQB)
Date:Mar 14, 2016
Previous Article:International Wire declares reduced net income for Q4 2015 year over year.
Next Article:STRATA Skin Sciences posts lower Q4 2015 net loss of USD0.6m.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters